First Trust Advisors LP bought a new position in shares of Monsanto Co. (NYSE:MON) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 127,865 shares of the company’s stock, valued at approximately $13,068,000.

Other hedge funds have also made changes to their positions in the company. Candriam Luxembourg S.C.A. acquired a new stake in shares of Monsanto during the second quarter worth approximately $12,767,000. Nisa Investment Advisors LLC boosted its stake in shares of Monsanto by 3.2% in the second quarter. Nisa Investment Advisors LLC now owns 189,692 shares of the company’s stock worth $19,616,000 after buying an additional 5,890 shares during the period. Shell Asset Management Co. boosted its stake in shares of Monsanto by 7.7% in the second quarter. Shell Asset Management Co. now owns 131,594 shares of the company’s stock worth $13,608,000 after buying an additional 9,459 shares during the period. Mondrian Investment Partners LTD boosted its stake in shares of Monsanto by 22.1% in the second quarter. Mondrian Investment Partners LTD now owns 785,779 shares of the company’s stock worth $81,257,000 after buying an additional 142,262 shares during the period. Finally, Carmignac Gestion purchased a new stake in shares of Monsanto during the second quarter worth about $197,555,000. 73.94% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Monsanto Co. (NYSE:MON) traded up 0.3533% during midday trading on Wednesday, hitting $102.7517. 674,184 shares of the stock traded hands. The firm has a market cap of $45.00 billion, a PE ratio of 34.3881 and a beta of 1.01. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26. The stock has a 50-day moving average of $100.97 and a 200 day moving average of $104.18.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The business’s quarterly revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.19) EPS. Equities analysts forecast that Monsanto Co. will post $4.73 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “First Trust Advisors LP Invests $13,068,000 in Monsanto Co. (MON)” was published by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The legal version of this piece of content can be viewed at http://www.dailypolitical.com/2016/11/30/first-trust-advisors-lp-invests-13068000-in-monsanto-co-mon.html.

MON has been the subject of a number of analyst reports. Vetr raised shares of Monsanto from a “buy” rating to a “strong-buy” rating and set a $117.09 price objective for the company in a research note on Wednesday, August 3rd. Monness Crespi & Hardt raised shares of Monsanto from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $106.93 to $130.00 in a research note on Monday, August 8th. Citigroup Inc. increased their price objective on shares of Monsanto from $112.00 to $116.00 and gave the stock a “neutral” rating in a research note on Friday, August 19th. Piper Jaffray Cos. reissued an “overweight” rating and issued a $118.00 price objective on shares of Monsanto in a research note on Sunday, August 21st. Finally, Zacks Investment Research raised shares of Monsanto from a “strong sell” rating to a “hold” rating in a research note on Tuesday, September 6th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and fifteen have assigned a buy rating to the company’s stock. Monsanto currently has a consensus rating of “Buy” and an average target price of $114.06.

In related news, Director Charles S. Mcmillan purchased 3,500 shares of the business’s stock in a transaction that occurred on Monday, October 10th. The stock was bought at an average price of $103.23 per share, with a total value of $361,305.00. Following the acquisition, the director now owns 64,009 shares in the company, valued at $6,607,649.07. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Kerry J. Preete sold 2,745 shares of the business’s stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $100.96, for a total transaction of $277,135.20. Following the completion of the sale, the executive vice president now directly owns 50,056 shares of the company’s stock, valued at approximately $5,053,653.76. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by corporate insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Co. (NYSE:MON).

Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.